Michael Roger Minogue is an American businessman, military veteran, and politician who is the Republican Party nominee for Governor of Massachusetts in the 2026 Massachusetts gubernatorial election. A former chairman, president and chief executive officer of medical-device manufacturer Abiomed, Minogue entered the gubernatorial race in October 2025 and defeated businessman and former Massachusetts Bay Transportation Authority executive Brian Shortsleeve in the September 2026 Republican primary.
Before entering politics, Minogue spent nearly two decades leading Abiomed, a Massachusetts-based medical technology company best known for the Impella heart pump. He served as chief executive beginning in 2004 and remained at the company until its acquisition by Johnson & Johnson in 2022 in a transaction valued at approximately $16.6 billion.
Early life and education
Michael Roger Minogue was born in Georgia and grew up in New Jersey, the son of an Air Force pilot. His campaign has described him as the youngest of four children in an Irish Catholic family and WBUR stated that he is a devout Irish Catholic.
Minogue entered the United States Military Academy at West Point in 1985. A company announcement shared after he joined Abiomed stated that he had graduate with a Bachelor of Science in engineering and afterwards earned an MBA from the University of Chicago. Later filings described the West Point degree as an engineering management degree.
Military service
After graduating from West Point, Minogue served on active duty in the United States Army for four years as an infantry officer. He was a Ranger-qualified platoon leader during Operation Desert Storm in the Gulf War. WBUR reported that he earned a Bronze Star Medal serving in Iraq in 1991. A later Insulet filing stated that he was an Airborne Ranger.
In 2016, Minogue told The Boston Globe that serving in infantry leadership meant "lead from the front," saying: "If you want to serve in these types of units, you have to serve something greater than yourself."
Business career
GE Medical Systems
After leaving active military service, Minogue began a career in the medical technology industry. He spent approximately twelve years with GE Medical Systems, holding a number of management positions in sales, marketing, cardiology, medical imaging, and information technology.
Among his positions at GE were general manager of the company's global positron emission tomography business, general manager of Americas cardiology and information technology sales, and vice president and general manager for Americas sales and marketing for GE Medical Systems Information Technology.
Abiomed
In April 2004, Minogue was appointed president and chief executive officer of Abiomed, a medical-device company headquartered in Danvers, Massachusetts. He also joined the company's board of directors. He became chairman of the board in 2005.
During Minogue's tenure, Abiomed increasingly shifted its focus from artificial-heart replacement technology toward technology intended to assist heart recovery. A major component of that transition was the company's acquisition and development of the Impella line of miniature heart pumps.
Former Abiomed board member Dorothy Puhy told WBUR that Minogue presented the company's board with the plan to acquire the German company that controlled the intellectual property for the Impella heart pump, a transaction she described as beginning Abiomed's transformation into a much larger company.
The company expanded significantly during Minogue's leadership, and the Impella became its principal product line. By the time Johnson & Johnson announced its acquisition of Abiomed in November 2022, the transaction valued the company at approximately $16.6 billion.
Johnson & Johnson completed its acquisition of Abiomed in December 2022. Minogue subsequently left the company.
Media reports estimated that Minogue personally received at least $153 million as a result of the transaction, with his total proceeds potentially substantially higher depending on his stock interests.
During Minogue's tenure, Abiomed also faced regulatory and legal scrutiny involving some of its products and business practices. Federal regulators issued warnings and recalls involving the company's heart pumps, and Abiomed reached a federal settlement in 2018 concerning allegations involving physician payments and kickbacks. Minogue has defended the company's record and has argued that criticism of Abiomed does not accurately represent its overall performance and impact.
Philanthropy
Minogue founded MedTechVets, a nonprofit organization intended to help military veterans transition into careers in the medical technology industry.
He and his wife also established the Michael & Renee Minogue Foundation. According to his campaign, the foundation supports organizations involved in education, veterans' programs, healthcare innovation, faith-based initiatives, and programs serving children.
Political activity
Before becoming a candidate himself, Minogue was a significant donor to Republican candidates and organizations at the state and national levels.
He supported former Massachusetts governor Charlie Baker and Republican U.S. Senate candidate John Deaton. Minogue also made substantial contributions to national Republican organizations and candidates, including the Republican National Committee.
According to reporting by The Boston Globe, Minogue had previously changed his Massachusetts voter registration from Republican to unenrolled in 2007 before registering again as a Republican in April 2025. Voting records reviewed by the newspaper indicated that while unenrolled he participated exclusively in Republican primaries.
Minogue and his wife also hosted or participated in fundraising activity associated with national Republican figures, including JD Vance. His support for President Donald Trump and other national Republicans became an issue raised by Democrats during his gubernatorial campaign.
2026 Massachusetts gubernatorial campaign
Campaign launch
On October 1, 2025, Minogue announced his candidacy for the Republican nomination for governor of Massachusetts in the 2026 Massachusetts gubernatorial election.
He entered a Republican field that initially included former Massachusetts secretary of housing and economic development Mike Kennealy and former Massachusetts Bay Transportation Authority chief administrator Brian Shortsleeve.
Minogue described himself as a political outsider and made his experience managing Abiomed a central component of his campaign. He argued that Massachusetts government should operate with greater financial accountability and efficiency and said his private-sector management experience qualified him to reform state government.
The campaign also emphasized affordability, public safety, economic competitiveness, housing, education, and government accountability.
Campaign financing
Minogue largely self-financed his campaign during its early stages. In October 2025, his first full month as a candidate, he contributed $1.5 million of his own money to the campaign while raising more than $373,000 from individual donors.
By March 2026, he had put approximately $12.5 million of his own money into the campaign, making him the best-funded Republican candidate in the race.
Minogue said that his personal financial resources would allow him to compete with Healey in the general election without being dependent on traditional political fundraising.
References